These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33438083)

  • 1. The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data.
    Briggs A; Nasser S; Hammerby E; Buchs S; Virchow JC
    J Patient Rep Outcomes; 2021 Jan; 5(1):6. PubMed ID: 33438083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.
    Kapoor M; Storrar W; Balls L; Brown TP; Mansur A; Hedley E; Jones T; Roberts C; Shirkey B; Dutton S; Luengo-Fernandez R; Little M; Dewey A; Marshall S; Fogg C; Boughton K; Rahman N; Yu LM; Bradding P; Howarth P; Chauhan AJ
    Health Technol Assess; 2019 Jun; 23(29):1-140. PubMed ID: 31232684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trial.
    Jackson D; Jenkins M; de Nigris E; Purkayastha D; Patel M; Ouwens M
    Qual Life Res; 2024 Apr; 33(4):1029-1039. PubMed ID: 38206455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study.
    Oppenheimer J; Kerstjens HA; Boulet LP; Hanania NA; Kerwin E; Moore A; Nathan RA; Peachey G; Pizzichini E; Slade D; Zarankaite A; Pavord ID
    J Allergy Clin Immunol Pract; 2024 May; ():. PubMed ID: 38777124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
    Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study to evaluate utility measure and health-related quality of life (HRQoL) among patients with severe uncontrolled asthma in Spain.
    Martínez Moragón E; Entrenas Costa LM; Sánchez-Covisa Hernández J; de Prado Moncusí A; Monteagudo Ruiz G
    J Asthma; 2024 Jan; 61(1):27-38. PubMed ID: 37647295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Li A; Chang AB
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.
    Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
    Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
    Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
    Kew KM; Evans DJ; Allison DE; Boyter AC
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for autumn exacerbations of asthma in children.
    Pike KC; Akhbari M; Kneale D; Harris KM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012393. PubMed ID: 29518252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes.
    Sullivan PW; Ghushchyan VH; Campbell JD; Globe G; Bender B; Magid DJ
    Qual Life Res; 2016 Dec; 25(12):3017-3026. PubMed ID: 27387417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy for asthma.
    Fortescue R; Kew KM; Leung MST
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD011293. PubMed ID: 32926419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics for exacerbations of asthma.
    Normansell R; Sayer B; Waterson S; Dennett EJ; Del Forno M; Dunleavy A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002741. PubMed ID: 29938789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate-Severe Symptoms.
    Singh D; Oosterholt S; Pavord I; Garcia G; Abhijith Pg ; Della Pasqua O
    Adv Ther; 2023 Oct; 40(10):4606-4625. PubMed ID: 37589831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
    Anderson DE; Kew KM; Boyter AC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.